Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - New York Stock Exchange, Inc. - US7616241052 - Common Stock - Currency: USD

41.27  -0.42 (-1.01%)

After market: 41.27 0 (0%)

Fundamental Rating

6

REX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. REX has an excellent financial health rating, but there are some minor concerns on its profitability. REX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year REX was profitable.
In the past year REX had a positive cash flow from operations.
REX had positive earnings in each of the past 5 years.
In the past 5 years REX always reported a positive cash flow from operatings.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

With a decent Return On Assets value of 9.45%, REX is doing good in the industry, outperforming 73.53% of the companies in the same industry.
REX's Return On Equity of 11.98% is in line compared to the rest of the industry. REX outperforms 55.39% of its industry peers.
REX's Return On Invested Capital of 8.88% is fine compared to the rest of the industry. REX outperforms 62.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for REX is significantly below the industry average of 28.75%.
The last Return On Invested Capital (8.88%) for REX is above the 3 year average (8.01%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.45%
ROE 11.98%
ROIC 8.88%
ROA(3y)7.82%
ROA(5y)5.11%
ROE(3y)10.07%
ROE(5y)6.57%
ROIC(3y)8.01%
ROIC(5y)4.94%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

REX's Profit Margin of 10.07% is in line compared to the rest of the industry. REX outperforms 45.10% of its industry peers.
In the last couple of years the Profit Margin of REX has grown nicely.
The Operating Margin of REX (11.30%) is worse than 64.71% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 15.53%, REX is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 11.3%
PM (TTM) 10.07%
GM 15.53%
OM growth 3Y120.63%
OM growth 5Y33.2%
PM growth 3Y108.65%
PM growth 5Y2.4%
GM growth 3Y29.27%
GM growth 5Y13.87%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

9

2. Health

2.1 Basic Checks

REX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, REX has more shares outstanding
The number of shares outstanding for REX has been reduced compared to 5 years ago.
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.32 indicates that REX is not in any danger for bankruptcy at the moment.
REX has a better Altman-Z score (6.32) than 92.16% of its industry peers.
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.32
ROIC/WACC0.98
WACC9.06%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 9.93. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.93, REX belongs to the top of the industry, outperforming 94.61% of the companies in the same industry.
REX has a Quick Ratio of 9.27. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
REX has a Quick ratio of 9.27. This is amongst the best in the industry. REX outperforms 95.10% of its industry peers.
Industry RankSector Rank
Current Ratio 9.93
Quick Ratio 9.27
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

REX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.41%, which is quite impressive.
REX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.15% yearly.
Looking at the last year, REX shows a very negative growth in Revenue. The Revenue has decreased by -20.58% in the last year.
The Revenue has been growing by 11.36% on average over the past years. This is quite good.
EPS 1Y (TTM)37.41%
EPS 3Y168.13%
EPS 5Y16.15%
EPS Q2Q%-7.38%
Revenue 1Y (TTM)-20.58%
Revenue growth 3Y30.77%
Revenue growth 5Y11.36%
Sales Q2Q%-20.9%

3.2 Future

The Earnings Per Share is expected to decrease by -4.31% on average over the next years.
Based on estimates for the next years, REX will show a decrease in Revenue. The Revenue will decrease by -2.61% on average per year.
EPS Next Y-13.84%
EPS Next 2Y-37.32%
EPS Next 3Y-4.31%
EPS Next 5YN/A
Revenue Next Year-23.95%
Revenue Next 2Y-9.04%
Revenue Next 3Y-2.61%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.80, which indicates a very decent valuation of REX.
Compared to the rest of the industry, the Price/Earnings ratio of REX indicates a somewhat cheap valuation: REX is cheaper than 61.76% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. REX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 30.27, which means the current valuation is very expensive for REX.
68.14% of the companies in the same industry are cheaper than REX, based on the Price/Forward Earnings ratio.
REX's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 10.8
Fwd PE 30.27
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

82.35% of the companies in the same industry are more expensive than REX, based on the Enterprise Value to EBITDA ratio.
REX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.87
EV/EBITDA 3.24
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

REX has a very decent profitability rating, which may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.31% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.67
EPS Next 2Y-37.32%
EPS Next 3Y-4.31%

0

5. Dividend

5.1 Amount

REX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (2/21/2025, 8:04:00 PM)

After market: 41.27 0 (0%)

41.27

-0.42 (-1.01%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)12-03 2024-12-03/bmo
Earnings (Next)05-20 2025-05-20/bmo
Inst Owners85.03%
Inst Owner Change-5.77%
Ins Owners13.72%
Ins Owner Change-0.06%
Market Cap725.11M
Analysts80
Price Target60.95 (47.69%)
Short Float %2.58%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)44.25%
Min EPS beat(2)-1.27%
Max EPS beat(2)89.77%
EPS beat(4)3
Avg EPS beat(4)49.98%
Min EPS beat(4)-1.27%
Max EPS beat(4)89.77%
EPS beat(8)6
Avg EPS beat(8)74.69%
EPS beat(12)9
Avg EPS beat(12)93.74%
EPS beat(16)13
Avg EPS beat(16)889.24%
Revenue beat(2)1
Avg Revenue beat(2)3.87%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)9.23%
Revenue beat(4)1
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)9.23%
Revenue beat(8)4
Avg Revenue beat(8)2.86%
Revenue beat(12)7
Avg Revenue beat(12)2.63%
Revenue beat(16)10
Avg Revenue beat(16)3.21%
PT rev (1m)0%
PT rev (3m)-4.02%
EPS NQ rev (1m)-54.1%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)-2.31%
EPS NY rev (3m)13.85%
Revenue NQ rev (1m)-4.85%
Revenue NQ rev (3m)-2.23%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 10.8
Fwd PE 30.27
P/S 1.08
P/FCF 24.87
P/OCF 7.26
P/B 1.28
P/tB 1.28
EV/EBITDA 3.24
EPS(TTM)3.82
EY9.26%
EPS(NY)1.36
Fwd EY3.3%
FCF(TTM)1.66
FCFY4.02%
OCF(TTM)5.68
OCFY13.77%
SpS38.24
BVpS32.13
TBVpS32.13
PEG (NY)N/A
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 9.45%
ROE 11.98%
ROCE 11.31%
ROIC 8.88%
ROICexc 19.46%
ROICexgc 19.46%
OM 11.3%
PM (TTM) 10.07%
GM 15.53%
FCFM 4.34%
ROA(3y)7.82%
ROA(5y)5.11%
ROE(3y)10.07%
ROE(5y)6.57%
ROIC(3y)8.01%
ROIC(5y)4.94%
ROICexc(3y)18.6%
ROICexc(5y)11.38%
ROICexgc(3y)18.6%
ROICexgc(5y)11.38%
ROCE(3y)10.2%
ROCE(5y)6.29%
ROICexcg growth 3Y208.14%
ROICexcg growth 5Y52.29%
ROICexc growth 3Y208.14%
ROICexc growth 5Y52.29%
OM growth 3Y120.63%
OM growth 5Y33.2%
PM growth 3Y108.65%
PM growth 5Y2.4%
GM growth 3Y29.27%
GM growth 5Y13.87%
F-Score7
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 419.63%
Cap/Sales 10.53%
Interest Coverage 250
Cash Conversion 107.62%
Profit Quality 43.1%
Current Ratio 9.93
Quick Ratio 9.27
Altman-Z 6.32
F-Score7
WACC9.06%
ROIC/WACC0.98
Cap/Depr(3y)108.89%
Cap/Depr(5y)78.59%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.14%
Profit Quality(3y)151.66%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.41%
EPS 3Y168.13%
EPS 5Y16.15%
EPS Q2Q%-7.38%
EPS Next Y-13.84%
EPS Next 2Y-37.32%
EPS Next 3Y-4.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.58%
Revenue growth 3Y30.77%
Revenue growth 5Y11.36%
Sales Q2Q%-20.9%
Revenue Next Year-23.95%
Revenue Next 2Y-9.04%
Revenue Next 3Y-2.61%
Revenue Next 5YN/A
EBIT growth 1Y40.68%
EBIT growth 3Y188.5%
EBIT growth 5Y48.33%
EBIT Next Year52.94%
EBIT Next 3Y24.97%
EBIT Next 5YN/A
FCF growth 1Y-66.57%
FCF growth 3YN/A
FCF growth 5Y19.47%
OCF growth 1Y4.84%
OCF growth 3Y145.96%
OCF growth 5Y21.72%